Lorraine A. Lebel

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Hans Rollema, Leslie K. Chambers, J.W. Coe et al. · Neuropharmacology · 2006 · 535 citations

Public Health, Pharmacology, Pharmacotherapy +14

4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants

Reinhard Sarges, Harry Howard, Ronald G. Browne et al. · Journal of Medicinal Chemistry · 1990 · 408 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 322 citations

Medicine, Pharmacology, Pharmacotherapy +15

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

Anne W. Schmidt, Lorraine A. Lebel, Harry Howard et al. · European Journal of Pharmacology · 2001 · 292 citations

Medicine, Pharmacology, Pharmacotherapy +11